Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival

CAR-T cell therapy is the most advanced way to treat therapy resistant hematologic cancers, in particular B cell lymphomas and leukemias, with high efficiency. Donor T cells equipped ex vivo with chimeric receptor recognize target tumor cells and kill them using lytic granules. CAR-T cells that reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalinin, R. S., Ukrainskaya, V. M., Chumakov, S. P., Moysenovich, A. M., Tereshchuk, V. M., Volkov, D. V., Pershin, D. S., Maksimov, E. G., Zhang, H., Maschan, M. A., Rubtsov, Y. P., Stepanov, A. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548718/
https://www.ncbi.nlm.nih.gov/pubmed/34722633
http://dx.doi.org/10.3389/fmolb.2021.745286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548718/
https://www.ncbi.nlm.nih.gov/pubmed/34722633
http://dx.doi.org/10.3389/fmolb.2021.745286

Ejemplares similares